Related Experiment Video
Updated: May 18, 2026

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma
Published on: May 11, 2015
Autoimmune biomarkers in glaucoma patients
Oliver W Gramlich1, Katharina Bell, Nadine von Thun Und Hohenstein-Blaul
1Experimental Ophthalmology, Department of Ophthalmology, University Medical Center of the Johannes Gutenberg University, Langenbeckstr. 1, 55131 Mainz, Germany.
Autoimmune processes and autoantibodies are implicated in glaucoma development. Imbalances in these natural autoantibodies may predispose individuals to glaucoma, highlighting autoimmune mechanisms in the disease.
Area of Science:
- Ophthalmology
- Immunology
- Neuroscience
Background:
- Growing evidence suggests autoimmune involvement in glaucoma pathogenesis.
- Alterations in natural autoantibody levels are key factors.
- Autoantibodies can have both detrimental and protective roles.
Purpose of the Study:
- To review recent advances in understanding autoimmune mechanisms in glaucoma.
- To highlight the role of natural autoantibodies in glaucoma pathogenesis.
Main Methods:
- Literature review of recent studies on autoimmunity and glaucoma.
- Analysis of the role of autoantibodies in neuroretinal cells.
- Examination of the impact of autoantibody disbalance on immune equilibrium.
Main Results:
- Upregulation of autoantibodies can be linked to severe conditions.
- Natural autoantibodies possess protective characteristics.
- Autoantibodies influence protein expression in neuroretinal cells.
Conclusions:
- A disbalance in natural autoantibodies can disrupt protective immunity.
- This disruption may lead to a predisposition for developing glaucoma.
- Understanding these autoimmune mechanisms is crucial for glaucoma research.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment

